Richard G Wunderink

  • 19699 Citations
1984 …2025

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

My research interests revolve around understanding the risk factors, including host genetic risk, and improving outcomes of critically ill patients with serious infections. This includes severe community-acquired pneumonia, sepsis of all causes, and nosocomial infections, particularly ventilator-associated pneumonia.

Certifications and Licenses

Internal Medicine
Critical Care Medicine
Pulmonary Disease

Training Experience

1983Residency, Butterworth Hospital
1985Fellowship, Henry Ford Hospital

Education/Academic qualification

MD, Indiana University Bloomington

… → 1980

Research interests

  • Critical Care
  • Critical Care Outcomes
  • Genetics: Medical
  • Pneumonia

Fingerprint Dive into the research topics where Richard G Wunderink is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Angiotensin i and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock

Bellomo, R., Wunderink, R. G., Szerlip, H., English, S. W., Busse, L. W., Deane, A. M., Khanna, A. K., McCurdy, M. T., Ostermann, M., Young, P. J., Handisides, D. R., Chawla, L. S., Tidmarsh, G. F. & Albertson, T. E., Feb 6 2020, In : Critical Care. 24, 1, 43.

Research output: Contribution to journalArticle

Open Access
  • Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia – Authors' reply

    Kollef, M. H., Réa-Neto, Á., Wunderink, R. G., Bruno, C. J. & Rhee, E. G., Jan 2020, In : The Lancet Infectious Diseases. 20, 1, p. 20-21 2 p.

    Research output: Contribution to journalLetter

    Open Access
  • Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial

    Niederman, M. S., Alder, J., Bassetti, M., Boateng, F., Cao, B., Corkery, K., Dhand, R., Kaye, K. S., Lawatscheck, R., McLeroth, P., Nicolau, D. P., Wang, C., Wood, G. C., Wunderink, R. G. & Chastre, J., Mar 2020, In : The Lancet Infectious Diseases. 20, 3, p. 330-340 11 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis

    Rello, J., Kalwaje Eshwara, V., Lagunes, L., Alves, J., Wunderink, R. G., Conway-Morris, A., Rojas, J. N., Alp, E. & Zhang, Z., Feb 4 2019, In : European Journal of Clinical Microbiology and Infectious Diseases. 38, 2, p. 319-323 5 p.

    Research output: Contribution to journalArticle

  • 11 Scopus citations